INTRODUCTION
Sialorrhea is a frequent, unbearable, disturbing and persistent adverse effect of antipsychotics, especially related with clozapine, risperidone, olanzapine. This is known as dose-related adverse effect (1) . This condition may be particularly socially stigmatizing and troubling for patients, resulting in treatment nonadherence or discontinuation (2) . Sialorrhea may emerge all day; however, its frequency and amount that is inversely proportional with ability to swallow, increases during sleep time (3) . The patients frequently complain of awakening with a "wet pillow" (2) .
Aripiprazole, which is a relatively new atypical antipsychotic, has been used in the treatment of schizophrenia, depression, bipolar disorder, tic disorders, irritability, impulsivity, and obsessive compulsive disorder (OCD) (4) (5) (6) . The common adverse effect of antipsychotics such as headaches, nausea, vomiting, somnolence, difficulty with speaking, anxiety, loss of balance, insomnia, weight gain, and restlessness have been observed relatively limited in using aripiprazole compared with the other antipsychotics. This safe and tolerable profile of aripiprazole is not valid for every side effect as sialorrhea and akathisia (7).
Here, we present a case of aripiprazole-induced sialorrhea responsive to amitriptyline in a male patient with first-time psychotic episode. receptor but M1 and M4 are fewer than it is thought that the cause of antipsychotic-induced sialorrhea can be one of these; to involve α2-adrenergic antagonism, M4 muscarinic agonism or laryngeal peristalsis/ inhibition of swallowing reflex (2, 12) . In this case report, the most likely mechanism of aripiprazole induced sialorrhea is through central α2-adrenergic antagonism as reported with risperidone (13) and clozapine (2).
CASE PRESENTATIONS
In the treatment of antipsychotics-induced sialorrhea is used α2-adrenergic receptor agonist or anticholinergic drugs (14) . Amitriptyline is a tricyclic antidepressant, which blocks serotonin and norepinephrine transporters, exerts α2-adrenergic receptor antagonism, M4 muscarinic receptor agonism, and reduces laryngeal peristalsis (15) .
Amitriptyline has been used to be useful in clozapineinduced sialorrhea (14, 15) . The treatment of sialorrhea with amitriptyline suggested to be the result of its multiple mechanisms may be responsible. In the treatment of sialorrhea with amitriptyline can be used in high doses (100 mg/day) (15).
In conclusion, it is important to be aware of the possibility of a sialorrhea being induced when starting aripiprazole therapy. Amitriptyline may be a therapeutic option for patients with aripiprazole-induced sialorrhea.
We believe that these case reports serve as a base for future research to examine the relationship between using aripiprazole, onset of sialorrhea, and treatment response.
